2018-2023 Global Genitourinary Drugs Consumption Market Report

August 2018 | 139 pages | ID: 250016CBBFFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Genitourinary Drugs market for 2018-2023.

A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.
The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pipeline drugs are expected to widen the scope for growth in the future.
Over the next five years, LPI(LP Information) projects that Genitourinary Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Genitourinary Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Urologicals
• Hormonal Therapy
• Gynecological
• Anti-infectives

Segmentation by application:

• Prostate Cancer
• Ovarian Cancer
• Bladder Cancer
• Cervical Cancer
• Renal Cancer
• Erectile Dysfunction
• Urinary Tract Infections
• Urinary Incontinence & Overactive Bladder
• Sexually Transmitted Diseases
• Interstitial Cystitis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Novartis AG
• Genentech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Genitourinary Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Genitourinary Drugs market by identifying its various subsegments.
• Focuses on the key global Genitourinary Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Genitourinary Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Genitourinary Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Genitourinary Drugs Consumption 2013-2023
  2.1.2 Genitourinary Drugs Consumption CAGR by Region
2.2 Genitourinary Drugs Segment by Type
  2.2.1 Urologicals
  2.2.2 Hormonal Therapy
  2.2.3 Gynecological
  2.2.4 Anti-infectives
2.3 Genitourinary Drugs Consumption by Type
  2.3.1 Global Genitourinary Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Genitourinary Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Genitourinary Drugs Sale Price by Type (2013-2018)
2.4 Genitourinary Drugs Segment by Application
  2.4.1 Prostate Cancer
  2.4.2 Ovarian Cancer
  2.4.3 Bladder Cancer
  2.4.4 Cervical Cancer
  2.4.5 Renal Cancer
  2.4.6 Erectile Dysfunction
  2.4.7 Urinary Tract Infections
  2.4.8 Urinary Incontinence & Overactive Bladder
  2.4.9 Sexually Transmitted Diseases
  2.4.10 Interstitial Cystitis
2.5 Genitourinary Drugs Consumption by Application
  2.5.1 Global Genitourinary Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Genitourinary Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Genitourinary Drugs Sale Price by Application (2013-2018)

3 GLOBAL GENITOURINARY DRUGS BY PLAYERS

3.1 Global Genitourinary Drugs Sales Market Share by Players
  3.1.1 Global Genitourinary Drugs Sales by Players (2016-2018)
  3.1.2 Global Genitourinary Drugs Sales Market Share by Players (2016-2018)
3.2 Global Genitourinary Drugs Revenue Market Share by Players
  3.2.1 Global Genitourinary Drugs Revenue by Players (2016-2018)
  3.2.2 Global Genitourinary Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Genitourinary Drugs Sale Price by Players
3.4 Global Genitourinary Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Genitourinary Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Genitourinary Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 GENITOURINARY DRUGS BY REGIONS

4.1 Genitourinary Drugs by Regions
  4.1.1 Global Genitourinary Drugs Consumption by Regions
  4.1.2 Global Genitourinary Drugs Value by Regions
4.2 Americas Genitourinary Drugs Consumption Growth
4.3 APAC Genitourinary Drugs Consumption Growth
4.4 Europe Genitourinary Drugs Consumption Growth
4.5 Middle East & Africa Genitourinary Drugs Consumption Growth

5 AMERICAS

5.1 Americas Genitourinary Drugs Consumption by Countries
  5.1.1 Americas Genitourinary Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Genitourinary Drugs Value by Countries (2013-2018)
5.2 Americas Genitourinary Drugs Consumption by Type
5.3 Americas Genitourinary Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Genitourinary Drugs Consumption by Countries
  6.1.1 APAC Genitourinary Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Genitourinary Drugs Value by Countries (2013-2018)
6.2 APAC Genitourinary Drugs Consumption by Type
6.3 APAC Genitourinary Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Genitourinary Drugs by Countries
  7.1.1 Europe Genitourinary Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Genitourinary Drugs Value by Countries (2013-2018)
7.2 Europe Genitourinary Drugs Consumption by Type
7.3 Europe Genitourinary Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Genitourinary Drugs by Countries
  8.1.1 Middle East & Africa Genitourinary Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Genitourinary Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Genitourinary Drugs Consumption by Type
8.3 Middle East & Africa Genitourinary Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Genitourinary Drugs Distributors
10.3 Genitourinary Drugs Customer

11 GLOBAL GENITOURINARY DRUGS MARKET FORECAST

11.1 Global Genitourinary Drugs Consumption Forecast (2018-2023)
11.2 Global Genitourinary Drugs Forecast by Regions
  11.2.1 Global Genitourinary Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Genitourinary Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Genitourinary Drugs Forecast by Type
11.8 Global Genitourinary Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Novartis AG
  12.1.1 Company Details
  12.1.2 Genitourinary Drugs Product Offered
  12.1.3 Novartis AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Novartis AG News
12.2 Genentech
  12.2.1 Company Details
  12.2.2 Genitourinary Drugs Product Offered
  12.2.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Genentech News

...

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Product Specifications of Genitourinary Drugs
Figure Genitourinary Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Geni